These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12954531)

  • 1. Kainic acid lesion-induced nigral neuronal death.
    Foster JA; Bezin L; Groc L; Christopherson PL; Levine RA
    J Chem Neuroanat; 2003 Aug; 26(1):65-73. PubMed ID: 12954531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
    Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution, and morphology of cell death.
    Stefanis L; Burke RE
    Neuroscience; 1996 Oct; 74(4):997-1008. PubMed ID: 8895868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
    Silva C; Fuxe K; Chadi G
    J Neural Transm Suppl; 2009; (73):185-202. PubMed ID: 20411778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
    Aoi M; Date I; Tomita S; Ohmoto T
    Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
    Canudas AM; Pezzi S; Canals JM; Pallàs M; Alberch J
    Brain Res Mol Brain Res; 2005 Mar; 134(1):147-54. PubMed ID: 15790538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat.
    Martí MJ; Saura J; Burke RE; Jackson-Lewis V; Jiménez A; Bonastre M; Tolosa E
    Brain Res; 2002 Dec; 958(1):185-91. PubMed ID: 12468044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat.
    Tan Y; Williams EA; Lancia AJ; Zahm DS
    Brain Res; 2000 Jun; 869(1-2):56-68. PubMed ID: 10865059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
    Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
    Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion.
    Zuch CL; Nordstroem VK; Briedrick LA; Hoernig GR; Granholm AC; Bickford PC
    J Comp Neurol; 2000 Nov; 427(3):440-54. PubMed ID: 11054705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.
    Panneton WM; Kumar VB; Gan Q; Burke WJ; Galvin JE
    PLoS One; 2010 Dec; 5(12):e15251. PubMed ID: 21179455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.
    Moore AE; Cicchetti F; Hennen J; Isacson O
    Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.
    Sauer H; Oertel WH
    Neuroscience; 1994 Mar; 59(2):401-15. PubMed ID: 7516500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons.
    Burke RE; Macaya A; DeVivo D; Kenyon N; Janec EM
    Neuroscience; 1992 Oct; 50(3):559-69. PubMed ID: 1359461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets.
    Corwin C; Nikolopoulou A; Pan AL; Nunez-Santos M; Vallabhajosula S; Serrano P; Babich J; Figueiredo-Pereira ME
    J Neuroinflammation; 2018 Sep; 15(1):272. PubMed ID: 30236122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic nicotine treatment differentially regulates substance P and tyrosine hydroxylase immunoreactivity in substantia nigra ipsilateral to a unilateral lesion.
    Janson AM; Fuxe K
    Exp Neurol; 1997 Aug; 146(2):575-86. PubMed ID: 9270071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.